Main content
NTRK gene fusions in solid tumors and TRK inhibitors: a systematic review of case reports and case series
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
Rationale and objectives
-
The rapidly expanding knowledge in genomics, proteomics, and transcriptomics has led to the discovery of new molecular alterations and markers of immune phenotypes shared by multiple tumor types regardless of their site of origin [1]. Since 2017, the Food and Drug Administration (FDA) has approved six anticancer agents with a "histology-agnostic" indication: two immune c…
Files
Files can now be accessed and managed under the Files tab.
Citation
Recent Activity
Unable to retrieve logs at this time. Please refresh the page or contact support@osf.io if the problem persists.